SwissHealthSaving.ch
Deductible guideNewcomers guidePremium subsidySwiss tax (opens in a new tab)

US Drug Prices and Swiss Health Insurance Premiums: What the New Numbers Show

Published 08.11.2026

US drug-pricing policy (most-favoured-nation pricing) is putting pressure on Swiss medicine prices. A new study by ETH Zurich and the University of Zurich estimates extra costs of several hundred million francs a year for Swiss premium payers if Switzerland and other countries raise prices. Your 2027 premium is not affected: 2027 premiums are already set, and medicines currently make up about 22% of basic insurance costs.

What the new ETH/University of Zurich study says

According to SRF (2 November 2026), a new study by ETH Zurich and the University of Zurich concludes that if Switzerland and other countries raise drug prices under US pressure, Swiss premium payers would pay several hundred million francs more per year. The study is based on data as of December 2025.

Background: the US compares its prices with around 19 reference countries, including Switzerland, and wants the lowest price among them. According to the study, Switzerland currently plays no decisive role, because its median prices are not among the lowest. South Korea most often had the lowest relevant reference price, followed by Norway and Australia (Blick, 2 November 2026).

Co-author Kerstin Vokinger warns of a price race between countries: in an extreme case US prices would not fall, but prices elsewhere would rise. She recommends coordinating with other countries.

How big the risk to premiums is

In May 2026, answering a parliamentary question, the Federal Council put a figure on an extreme scenario in which US pricing decisions spill over to Switzerland (Blick, 23 May 2026): up to CHF 4.8 billion in extra costs for premium payers, about CHF 530 per person per year, and annual extra costs of up to CHF 7.6 billion by 2034. The ETH/UZH study's estimate of several hundred million francs a year is a much lower order of magnitude.

The Federal Office of Public Health (FOPH/BAG) rejects across-the-board price increases, saying it is uncertain whether the US pricing models will last, although manufacturers already use the argument in price negotiations (SRF). Industry association Interpharma says a member survey found that a third of approved medicines are currently not submitted to the FOPH for reimbursement; the FOPH says the number of applications is similar to last year.

For scale: medicines cost basic insurance CHF 9,687 million in 2025, or 22% of gross benefits, equal to CHF 89 per insured person per month (priminfo, FOPH statistics 2025).

IndicatorValueSource
Medicine costs in basic insurance 2025CHF 9,687m (22%)priminfo / FOPH
Medicine costs per person per monthCHF 89priminfo / FOPH
ETH/UZH study: extra cost if prices riseseveral hundred million CHF a yearSRF, 2 Nov 2026
Federal Council worst case for premium payersup to CHF 4.8bn (approx. CHF 530 per person/year)Blick, 23 May 2026
Federal Council annual extra cost by 2034up to CHF 7.6bnBlick, 23 May 2026

What this means for your 2027 premium

The 2027 premiums have been approved by the FOPH and apply from 1 January 2027. Any round of drug-price increases would only show up in later premium years. In the short term, what you pay in 2027 depends on your insurer, deductible and insurance model. Basic insurance benefits are identical at every insurer by law.

Our analysis of the official 2027 premiums (adults, CHF 300 deductible, without accident cover) shows: across the 42 premium regions, the standard model costs CHF 571.89 a month on average, while the cheapest offer in an alternative model costs CHF 458.70. The gap averages CHF 1,358.38 a year, which is more than the CHF 530 in the Federal Council's worst-case scenario.

Canton (region)Avg standard premium 2027Cheapest offer (all models)Difference per year
Switzerland (avg of 42 regions)CHF 571.89CHF 458.70CHF 1,358.38
Zurich (1)CHF 634.04CHF 503.50CHF 1,566.42
Bern (1)CHF 658.64CHF 529.45CHF 1,550.24
Lucerne (1)CHF 553.46CHF 445.00CHF 1,301.47
AargauCHF 558.46CHF 451.00CHF 1,289.47
St. Gallen (1)CHF 567.50CHF 460.00CHF 1,290.00
Basel-StadtCHF 698.38CHF 558.70CHF 1,676.11
ZugCHF 419.57CHF 332.50CHF 1,044.87
Vaud (1)CHF 672.57CHF 546.30CHF 1,515.20
GenevaCHF 729.17CHF 568.90CHF 1,923.23
Ticino (1)CHF 726.70CHF 585.90CHF 1,689.54

Monthly values; difference = (avg standard premium − cheapest offer) × 12. Source: official 2027 premium data, own analysis.

Medicine costs: the rules that already apply

Basic insurance only reimburses medicines on the List of Pharmaceutical Specialities (SL); the FOPH checks effectiveness, appropriateness and cost-effectiveness. According to the FOPH, medicine costs have risen by about 50% over the past ten years, driven mainly by expensive new drugs for cancer, rare diseases, diabetes and obesity.

Your co-payment (Selbstbehalt) on medicines is normally 10%. If a cheaper alternative with the same active ingredient exists (generic or biosimilar) and you take the original, the co-payment rises to 40% (Helsana).

The insurers' association prio.swiss is calling for no SL price increases because of the US tariff debate. According to prio.swiss, the Federal Council confirmed in its answers to motions 25.4379 and 25.4173 that it plans no such increases. The FOPH estimates that the cost-consequence model for high-revenue drugs could save CHF 300–400 million a year.

What you can compare before 30 November

The usual deadlines apply for 2027. What counts is the date your insurer receives the letter, not the postmark; the FOPH recommends sending your cancellation by 15 November by registered mail or A-Post Plus.

  • Insurer: your basic insurance cancellation must arrive by Monday, 30 November 2026; the switch takes effect on 1 January 2027.
  • Deductible: CHF 300 to CHF 2,500 for adults. Report a lower deductible by 30 November, a higher one by 31 December 2026.
  • Model: report a change of model for 1 January by 30 November; according to the FOPH, moving from the standard model to an alternative model is possible at any time.
  • Benefits: identical in basic insurance at every insurer; only the premium, deductible and model differ.
Compare your premium now →

Frequently asked questions

Will Swiss health insurance premiums rise because of US drug prices?

Not for 2027: 2027 premiums are already set. A new ETH/UZH study estimates possible extra costs of several hundred million francs a year if Switzerland raises prices. The FOPH rejects across-the-board price increases.

How much could it cost per person?

In May 2026 the Federal Council named a worst case of up to CHF 4.8 billion for premium payers, about CHF 530 per person per year. The ETH/UZH study from November 2026 estimates much lower extra costs of several hundred million francs a year.

What share of basic insurance costs goes on medicines?

In 2025, CHF 9,687 million or 22% of gross benefits went on medicines, equal to CHF 89 per insured person per month (FOPH statistics via priminfo).

How big is the gap between the standard model and the cheapest offer in 2027?

Across the 42 premium regions it averages CHF 1,358.38 a year for adults with a CHF 300 deductible and no accident cover (avg standard CHF 571.89 vs cheapest offer CHF 458.70 a month). Cancellation must reach your insurer by 30 November 2026.

Sources

Related

We compare and inform — we do not provide advice.